INS and Insulin resistance: Among the eight miRNAs selected in the present work, some have been described as differentially expressed in insulin-sensitive tissues involved in the pathogenesis of the metabolic syndrome and insulin resistance (i.e., pancreatic islets, liver, adipose tissue, skeletal muscle and endothelium).